Literature DB >> 15682269

Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons.

C T Mendes1, W F Gattaz, E L Schaeffer, O V Forlenza.   

Abstract

In neurons, phospholipase A2 (PLA2) plays a central role in the regulation of membrane phospholipid metabolism. We have addressed the pharmacological modulation of PLA2 in primary cultures of rat cortical neurons. Inhibition curves were obtained in 4 day-in-culture neurons treated for 30 minutes with either the dual PLA2 inhibitor methyl arachidonyl fluorophosphonate (MAFP), or the iPLA2 inhibitor bromoenol lactone (BEL). Full inhibition was achieved with 100 and 250 microM of MAFP, or 10 and 20 microM of BEL. Conversely, a dose-dependent activation of PLA2 was obtained with 10-20 microg/ml of melitin. PLA2 inhibition with MAFP or BEL was not acutely toxic for cultured neurons. However, sustained inhibition of the enzyme precluded the development of neurites, and resulted in long-term loss of neuronal viability. We present a model of pharmacological challenge of PLA2 in vitro, which can be further used to address the involvement of the enzyme in neurodevelopment and neurodegeneration models.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682269     DOI: 10.1007/s00702-004-0271-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

1.  Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

Authors:  J K Yao; S Leonard; R D Reddy
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

2.  Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues.

Authors:  T J Nevalainen; T J Haapanen
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

3.  Activation of high levels of endogenous phospholipase A2 in cultured cells.

Authors:  W T Shier
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase.

Authors:  K Hattori; H Adachi; A Matsuzawa; K Yamamoto; M Tsujimoto; J Aoki; M Hattori; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

5.  Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes.

Authors:  D T Stephenson; J V Manetta; D L White; X G Chiou; L Cox; B Gitter; P C May; J D Sharp; R M Kramer; J A Clemens
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

6.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

7.  Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.

Authors:  J K Blusztajn; M Liscovitch; U I Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Decreased phospholipase A2 activity in Alzheimer brains.

Authors:  W F Gattaz; A Maras; N J Cairns; R Levy; H Förstl
Journal:  Biol Psychiatry       Date:  1995-01-01       Impact factor: 13.382

9.  Membrane lipid degradation is related to interictal cortical activity in a series of seizures.

Authors:  F Visioli; E B Rodriguez de Turco; N R Kreisman; N G Bazan
Journal:  Metab Brain Dis       Date:  1994-06       Impact factor: 3.584

10.  Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

Authors:  W F Gattaz; N J Cairns; R Levy; H Förstl; D F Braus; A Maras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

View more
  14 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6.

Authors:  Mikhail Strokin; Kevin L Seburn; Gregory A Cox; Kimberly A Martens; Georg Reiser
Journal:  Hum Mol Genet       Date:  2012-03-22       Impact factor: 6.150

Review 3.  Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.

Authors:  Grace Y Sun; Yan He; Dennis Y Chuang; James C Lee; Zezong Gu; Agnes Simonyi; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2012-04-03       Impact factor: 5.590

Review 4.  Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.

Authors:  James C-M Lee; Agnes Simonyi; Albert Y Sun; Grace Y Sun
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

Review 5.  The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  O V Forlenza; E L Schaeffer; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2006-11-27       Impact factor: 3.575

6.  Role of calcium-independent phospholipase A2 in cortex striatum thalamus cortex circuitry-enzyme inhibition causes vacuous chewing movements in rats.

Authors:  Li-Yen Lee; Wei-Yi Ong; Akhlaq A Farooqui; Jean-Marc Burgunder
Journal:  Psychopharmacology (Berl)       Date:  2007-09-04       Impact factor: 4.530

Review 7.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

8.  Calcium-independent phospholipase A2 mediates store-operated calcium entry in rat cerebellar granule cells.

Authors:  Karthika Singaravelu; Christian Lohr; Joachim W Deitmer
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  The cytotoxic effect of bromoenol lactone, a calcium-independent phospholipase A2 inhibitor, on rat cortical neurons in culture.

Authors:  Shiro Kurusu; Kohtaro Matsui; Toshimichi Watanabe; Toshinobu Tsunou; Mitsumori Kawaminami
Journal:  Cell Mol Neurobiol       Date:  2008-06-05       Impact factor: 5.046

Review 10.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.